4//SEC Filing
Dummer Wolfgang 4
Accession 0001179110-21-000986
CIK 0001034842other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 7:10 PM ET
Size
8.2 KB
Accession
0001179110-21-000986
Insider Transaction Report
Form 4
Dummer Wolfgang
Chief Medical Officer
Transactions
- Award
Stock Option(right to buy)
2021-01-27+125,000→ 125,000 totalExercise: $3.54Exp: 2031-01-27→ Common Stock (125,000 underlying) - Award
Stock Option (right to buy)
2021-01-27+37,500→ 37,500 totalExercise: $2.38Exp: 2030-08-25→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2021, subject to the reporting person's continuous service to the issuer through each such period.
- [F2]The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 27, 2021, it was determined that the performance metric had been met.
- [F3]The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of December 18, 2020, subject to the reporting person's continuous service to the issuer through each such period.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001749991
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 7:10 PM ET
- Size
- 8.2 KB